nipro corp (8086:Tokyo)
Transactions by NIPRO CORP (8086) in the last 6 months
Nipro Corporation (TSE:8086) signed a contract to acquire medical business from Unitika Ltd. (TSE:3103) on January 26, 2015. Unitika aims to concentrate on the growth of its management resources. The medical business reported sales of ¥1.4 billion and operating profit of ¥88 million for the period ending March 2014. About 90 employees working at the Okazaki Plant (Okazaki-shi, Aichi) will be transferred to Nipro. The deal has been resolved by the Board of Unitika. The ...
Dongduk Medical Corporation announced that it will receive KRW 2 billion in an equity round of funding from new investor, Nipro Corporation on December 3, 2014. The transaction is by way of third party capital increase in the company. As part of the transaction, the investor will acquire 33.33% stake in the company. On closing of the investment, the name of the company will change to Nipro Dongduk Medical Corporation.
Nipro Corporation (TSE:8086) agreed to acquire the remaining 48.33% stake in Cell Science & Technology Institute, Inc. from MEDINET Co., Ltd. (TSE:2370), Funakoshi Co.,Ltd. and Takeshi Sato for approximately ¥210 million on November 21, 2014. For every 90 shares of NIPRO Corp will swap one share of Cell Science & Technology Institute, Inc. Nipro will furnish 0.21 million common shares (tentative) for the share exchange. The shares to be allocated will be held treasury ...
MEDINET Co., Ltd.
|Dr Reddy's Laboratories Ltd||3,395 INR||+84.80|
|Fuso Pharmaceutical Industries Ltd||¥310.00 JPY||-1.00|
|JMS Co Ltd||¥297.00 JPY||0.00|
|Nikkiso Co Ltd||¥1,102 JPY||-19.00|
|NxStage Medical Inc||$18.27 USD||-0.06|
|View Industry Companies|